Reviva Book Value Per Share from 2010 to 2024

RVPHW Stock  USD 0.22  0.01  4.35%   
Reviva Pharmaceuticals Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Reviva Pharmaceuticals Holdings according to its financial statements. View All Fundamentals
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
0.24030033
Current Value
0.45
Quarterly Volatility
1.83111577
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Reviva Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 10 K, Net Interest Income of 523.9 K or Interest Income of 523.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 22.5. Reviva financial statements analysis is a perfect complement when working with Reviva Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Reviva Pharmaceuticals Correlation against competitors.

Latest Reviva Pharmaceuticals' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Reviva Pharmaceuticals Holdings over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Reviva Pharmaceuticals' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reviva Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.20 X10 Years Trend
Slightly volatile
   Book Value Per Share   
       Timeline  

Reviva Book Value Per Share Regression Statistics

Arithmetic Mean(1.26)
Geometric Mean1.69
Coefficient Of Variation(145.35)
Mean Deviation1.60
Median(2.46)
Standard Deviation1.83
Sample Variance3.35
Range4.8851
R-Value0.73
Mean Square Error1.66
R-Squared0.54
Significance0
Slope0.30
Total Sum of Squares46.94

Reviva Book Value Per Share History

2024 0.45
2023 0.24
2022 0.63
2021 1.94
2020 2.43

Other Fundumenentals of Reviva Pharmaceuticals

Reviva Pharmaceuticals Book Value Per Share component correlations

About Reviva Pharmaceuticals Financial Statements

Reviva Pharmaceuticals investors use historical fundamental indicators, such as Reviva Pharmaceuticals' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Reviva Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Book Value Per Share 0.24  0.45 
Tangible Book Value Per Share 0.24  0.45 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Reviva Stock Analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.